Uterine Serous Carcinoma Not Yet Recruiting Phase 2 Trials for Azenosertib (DB18028)

IndicationStatusPhase
DBCOND0122528 (Uterine Serous Carcinoma)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06369155Azenosertib in Uterine Serous Carcinoma: Biomarker StudyTreatment